"Designing Growth Strategies is in our DNA"

Schizophrenia Drugs Market Size, Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026

Region : Global | Format: PDF | Report ID: FBI101531

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Increasing Adoption of Long Acting Injectable (LAIs) as a Form of Treatment
    2. Prevalence of Schizophrenia Disorders by Key Regions
    3. New Product Launches
    4. Pipeline Analysis
    5. Regulatory Scenario By Key Regions
    6. Analysis of First Generation Antipsychotics versus Second & Third Generation Antipsychotics
    7. Overview of R&D Initiatives in Schizophrenia Treatment
  5. Global Schizophrenia Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis, Insights and Forecast – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Schizophrenia Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Schizophrenia Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Schizophrenia Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Schizophrenia Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Schizophrenia Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. H. Lundbeck A/S
      2. Otsuka Pharmaceutical Co., Ltd.
      3. Janssen Pharmaceuticals, Inc.
      4. Eli Lilly and Company
      5. AstraZeneca
      6. ALLERGAN
      7. Vanda Pharmaceuticals Inc.
      8. Sumitomo Dainippon Pharma Co., Ltd.
      9. Alkermes plc
      10. Bristol-Myers Squibb Company
      11. Other Prominent Players
  12. Strategic Recommendations

 

Read Less

Figure 1:  Global Schizophrenia Drugs Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2018 & 2026

Figure 3:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Second Generation, 2015-2026

Figure 4:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Third Generation, 2015-2026

Figure 5:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Others, 2015-2026

Figure 6:  Global Schizophrenia Drugs Market Value Share (%), by Treatment, 2018 & 2026

Figure 7:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Oral, 2015-2026

Figure 8:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Injectable, 2015-2026

Figure 9:  Global Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 10:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Hospital Pharmacies, 2015-2026

Figure 11:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Retail Pharmacies, 2015-2026

Figure 12:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Online Pharmacies, 2015-2026

Figure 13:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Others, 2015-2026

Figure 14:  Global Schizophrenia Drugs Market Value (US$ Mn), by Region, 2018 & 2026

Figure 15:  North America Schizophrenia Drugs Market Value (US$ Mn), by Therapeutic Class, 2018 & 2026

Figure 16:  North America Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2018

Figure 17:  North America Schizophrenia Drugs Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 18:  North America Schizophrenia Drugs Market Value Share (%), by Treatment, 2018

Figure 19:  North America Schizophrenia Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 20:  North America Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 21:  North America Schizophrenia Drugs Market Value (US$ Mn), By Country, 2018 & 2026

Figure 22:  North America Schizophrenia Drugs Market Value Share (%), By Country, 2018

Figure 23:  Europe Schizophrenia Drugs Market Value (US$ Mn), by Therapeutic Class, 2018 & 2026

Figure 24:  Europe Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2018

Figure 25:  Europe Schizophrenia Drugs Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 26:  Europe Schizophrenia Drugs Market Value Share (%), by Treatment, 2018

Figure 27:  Europe Schizophrenia Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 28:  Europe Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 29:  Europe Schizophrenia Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 30:  Europe Schizophrenia Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 31:  Asia Pacific Schizophrenia Drugs Market Value (US$ Mn), by Therapeutic Class, 2018 & 2026

Figure 32:  Asia Pacific Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2018

Figure 33:  Asia Pacific Schizophrenia Drugs Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 34:  Asia Pacific Schizophrenia Drugs Market Value Share (%), by Treatment, 2018

Figure 35:  Asia Pacific Schizophrenia Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 36:  Asia Pacific Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 37:  Asia Pacific Schizophrenia Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 38:  Asia Pacific Schizophrenia Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 39:  Latin America Schizophrenia Drugs Market Value (US$ Mn), by Therapeutic Class, 2018 & 2026

Figure 40:  Latin America Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2018

Figure 41:  Latin America Schizophrenia Drugs Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 42:  Latin America Schizophrenia Drugs Market Value Share (%), by Treatment, 2018

Figure 43:  Latin America Schizophrenia Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 44:  Latin America Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 45:  Latin America Schizophrenia Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 46:  Latin America Schizophrenia Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 47:  Middle East & Africa Schizophrenia Drugs Market Value (US$ Mn), by Therapeutic Class, 2018 & 2026

Figure 48:  Middle East & Africa Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2018

Figure 49:  Middle East & Africa Schizophrenia Drugs Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 50:  Middle East & Africa Schizophrenia Drugs Market Value Share (%), by Treatment, 2018

Figure 51:  Middle East & Africa Schizophrenia Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 52:  Middle East & Africa Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 53:  Middle East & Africa Schizophrenia Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 54:  Middle East & Africa Schizophrenia Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 55:  Global Schizophrenia Drugs Market Share (%), By Company, 2018

 

Table 1:  Global Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015–2026

Table 2:  Global Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 3:  Global Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 4:  Global Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 5:  North America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015-2026

Table 6:  North America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 7:  North America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 8:  North America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 9:  Europe Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015-2026

Table 10:  Europe Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 11:  Europe Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 12:  Europe Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 13:  Asia Pacific Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015-2026

Table 14:  Asia Pacific Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 15:  Asia Pacific Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 16:  Asia Pacific Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 17:  Latin America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015-2026

Table 18:  Latin America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 19:  Latin America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 20:  Latin America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 21:  Middle East & Africa Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015-2026

Table 22:  Middle East & Africa Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 23:  Middle East & Africa Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 24:  Middle East & Africa Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Booklet
  • Oct, 2019
  • 2018
  • 2015-2017
  • 134

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $6850
    Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- UGlobal hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X